A vaccine sponsored by Moderna has also submitted to the FDA for Emergency Use Authorization, based on data of effectiveness and safety in their phase 3 trial. AstraZeneca has also submitted preliminary information on their COVID-19 vaccine to the FDA based on data from phase 3 trials. As of...
A poster made by local health authorities to encourage seniors to undergo COVID-19 vaccination. Meanwhile, some 16.5 million citizens, aged between 3 and 17 years, have taken two shots of the vaccine, accounting for 71.02 perc...
COVID-19 vaccinesFERTILIZATION in vitroVACCINATION complicationsINDUCED ovulationIntroduction: Studies on the effect of vaccine type and two other vaccines other than inactivated vaccines approved in China on in vitro fertilization (IVF) pregnancy outcomes are rare. To compleme...
[1] Zhu FC, Li YH, Guan XH, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation,open-label, non-randomised, first-in-human trial. Lancet. 2020. 395(10240): 1845-1854. [2] Zhu FC, Guan XH, Li YH, et al...
Can I select which coronavirus vaccine type I get? It's uncertain if you'll have your choice of which vaccine brand or type you'll get. This may depend on how many doses of the vaccine are available in your area and where you are in line to receive it. When you schedule your appoi...
Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study 2022, Diabetes, Obesity and Metabolism COVID-19 Vaccine Hesitancy and Associated Factors among Diabetes Patients: A Cross-Sect...
1). We also observed that the risk also increases when carrying out indoor activities, more density of COVID-19 cases, vaccine type, previous chronic illnesses, male sex, and presence of variants of concern (see Table 3). We additionally implemented the code in the form of a streamlined ...
whereas effectiveness is drawn from real-world observations. Vaccine efficacies cannot be readily compared because the efficacy can be affected by factors including the vaccine itself (e.g., vaccine type, dose, and number of doses, etc.), the virus (e.g., the virulence of the viral variant...
"If the vaccine immunity wanes as rapidly, and it is necessary to re-vaccinate every couple of years, they will likely need to develop a non-adenovirus type 5 based vaccine for the repeated vaccine," Schooley said. He also stressed the importance of global cooperation in COVID-19 vaccine ...
Vaccine type:mRNA in two doses. Regulatory status:In addition to approvals in the UK, US, EU and Israel, a rolling review of trial data is under way by regulators in Canada, Singapore and Switzerland. Key dates: December 19:Approved for use in the US ...